TCW Group’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.25M Buy
+132,052
New +$3.05M 0.02% 243
2022
Q3
Sell
-37,869
Closed -$744K 302
2022
Q2
$744K Buy
37,869
+88
+0.2% +$2.08K 0.01% 270
2022
Q1
$986K Sell
37,781
-984
-3% -$26.2K 0.01% 264
2021
Q4
$1.1M Sell
38,765
-134
-0.3% -$4.17K 0.01% 282
2021
Q3
$1.24M Sell
38,899
-26,441
-40% -$887K ﹤0.01% 276
2021
Q2
$2.27M Sell
65,340
-7,510
-10% -$248K 0.02% 257
2021
Q1
$2.15M Buy
72,850
+9,434
+15% +$290K 0.02% 249
2020
Q4
$1.95M Buy
63,416
+10,741
+20% +$328K 0.02% 251
2020
Q3
$1.47M Buy
52,675
+3,368
+7% +$85.4K 0.02% 246
2020
Q2
$1.06M Buy
49,307
+1,226
+3% +$27.1K 0.01% 241
2020
Q1
$1.08M Buy
+48,081
New +$1.32M 0.01% 237

Other funds holding ELAN

TCW Group's ELAN Position: Q2 2026 in Review

TCW Group opened a new position in Elanco Animal Health (ELAN) in Q2 2026: 132,052 shares worth $3.25M. The stake represents 0.02% of the portfolio and ranks #243 among its holdings. This is a return to the name: TCW Group previously reported a position in ELAN as recently as Q2 2022.

TCW Group first reported a position in ELAN in Q1 2020 and has held it in 11 quarters since. 522 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • TCW Group held 132,052 shares of Elanco Animal Health worth $3.25M as of Q2 2026.
  • Elanco Animal Health was a new TCW Group position in Q2 2026.
  • Elanco Animal Health made up 0.02% of TCW Group's portfolio in Q2 2026, its #243 holding.
  • TCW Group first reported a position in Elanco Animal Health in Q1 2020 and has held it in 11 quarters since.
  • 522 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on TCW Group's 13F filing for Q2 2026, filed 3 Aug 2026.